Autolus Therapeutics Ltd

Stock Chart, Company Information, and Scan Results

$2.31(as of Aug 6, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Autolus Therapeutics Ltd Company Information, Fundamentals, and Technical Indicators

Stock Price$2.31
Ticker SymbolAUTL
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees647
CountyUSA
Market Cap$630.7M
EBIDTA-259.1M
10-Day Moving Average2.44
P/E Ratio-2.58
20-Day Moving Average2.47
Forward P/E Ratio0.00
50-Day Moving Average2.28
Earnings per Share-0.88
200-Day Moving Average2.28
Profit Margin-781.13%
RSI45.32
Shares Outstanding266.1M
ATR0.14
52-Week High5.00
Volume1,594,255
52-Week Low1.11
Most Recent Support Level2.23
Book Value371.1M
Most Recent Resistance Level2.42
P/B Ratio1.66
Upper Keltner2.78
P/S Ratio68.22
Lower Keltner2.17
Debt-to-Equity Ratio2.78
Next Earnings Date08/12/2025
Cash Surplus29.2M
Next Ex-Dividend DateUnknown

Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in United Kingdom and internationally. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which is in a Phase 1 clinical trial in pediatric patients with relapsed or refractory ALL; AUTO4, a programmed T cell investigational therapy for the treatment of peripheral T-cell lymphoma targeting TRBC1 and TRBC2; AUTO6NG, a programmed T cell investigational therapy targeting GD2 in development for the treatment of neuroblastoma; and AUTO8, a product candidate to treat multiple myeloma. It focuses on developing AUTO5, a preclinical TRBC2 programmed T cell product candidate for the treatment of peripheral T-cell lymphoma. The company was incorporated in 2014 and is headquartered in London, the United Kingdom.

Autolus Therapeutics Ltd In Our Stock Scanner

As of Aug 07, 2025
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Golden CrossScan Type: Stock Indicator Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.